{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:18:25Z","timestamp":1788257905951,"version":"build-2803163510"},"reference-count":27,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["PNRR-POC-2022-12375884"],"award-info":[{"award-number":["PNRR-POC-2022-12375884"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"award":["PNRR-POC-2022-12375884"],"award-info":[{"award-number":["PNRR-POC-2022-12375884"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Phosphorylated ACC (pACC), a downstream effector of the LKB1\/AMPK pathway, may support tumor bioenergetics and exert a tumor-promoting role in glioblastoma (GBM). In the randomized REGOMA trial, pACC expression was associated with improved overall survival (OS) in GBM patients treated with regorafenib, but its validity in large cohorts is unclear. This study aimed to characterize pACC and phosphorylated AMPK (pAMPK) expression in a real-world GBM cohort and to assess their prognostic and predictive value in patients receiving second-line regorafenib or fotemustine\/lomustine. In this retrospective, multicenter translational study, pACC and pAMPK were assessed by immunohistochemistry on FFPE tumor sections from 174 IDH-wild-type GBM patients treated with regorafenib (n = 84) or fotemustine\/lomustine (n = 90). Staining was performed with a validated anti-pACC monoclonal antibody and quantified by digital pathology. Survival analyses included univariable and multivariable Cox proportional hazards models, with interaction testing. pACC and pAMPK were expressed in 85.6% and 95.4% of samples, respectively, with heterogeneous spatial patterns. Neither marker was significantly associated with OS in the univariable analyses, and neither retained independent prognostic value in multivariable analysis. Regorafenib was associated with significantly longer OS than alkylating agents (10.4 vs. 6.3 months; p = 0.0021). However, the treatment-by-pACC interaction test was not statistically significant (adjusted p = 0.610), providing no formal evidence of a differential treatment effect by pACC status. Although pACC-positive expression was enriched among patients experiencing longer overall survival under regorafenib, formal treatment-by-biomarker interaction was non-significant. These exploratory findings indicate that pACC is not an established predictive biomarker and warrant prospectively powered evaluation.<\/jats:p>","DOI":"10.3390\/ijms27177789","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:48:36Z","timestamp":1788256116000},"page":"7789","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AMPK Pathway Activation Markers in GBM: Expression Patterns and Clinical Associations in a Real-World Study"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9492-2123","authenticated-orcid":false,"given":"Federica","family":"Ferrarini","sequence":"first","affiliation":[{"name":"Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6597-0265","authenticated-orcid":false,"given":"Paola","family":"Del Bianco","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"software","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"}]},{"given":"Martina","family":"Corr\u00e0","sequence":"additional","affiliation":[{"name":"Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-4934","authenticated-orcid":false,"given":"Tiziana","family":"Talienti","sequence":"additional","affiliation":[{"name":"UOC Radioterapia Oncologica, Ente Ecclesiastico Ospedale F Miulli, 70021 Acquaviva delle Fonti (BA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5299-994X","authenticated-orcid":false,"given":"Matteo","family":"Mauceri","sequence":"additional","affiliation":[{"name":"Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9919-1764","authenticated-orcid":false,"given":"Daniele","family":"Boso","sequence":"additional","affiliation":[{"name":"Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"given":"Giusi","family":"Romanazzi","sequence":"additional","affiliation":[{"name":"UOC Radioterapia Oncologica, Ente Ecclesiastico Ospedale F Miulli, 70021 Acquaviva delle Fonti (BA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3678-3372","authenticated-orcid":false,"given":"Martina","family":"Bedeschi","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola (FC), Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0059-5660","authenticated-orcid":false,"given":"Mario","family":"Caccese","sequence":"additional","affiliation":[{"name":"Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"data-curation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7362-3127","authenticated-orcid":false,"given":"Marta","family":"Padovan","sequence":"additional","affiliation":[{"name":"Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"}]},{"given":"Angela","family":"Guerriero","sequence":"additional","affiliation":[{"name":"Surgical Pathology and Cytopathology Unit, Department of Medicine-DIMED, University of Padua School of Medicine, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"validation","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"given":"Giovanni","family":"Esposito","sequence":"additional","affiliation":[{"name":"Immunology and Molecular Oncology Diagnostics, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9880-8387","authenticated-orcid":false,"given":"Isacco","family":"Desideri","sequence":"additional","affiliation":[{"name":"Radiation Oncology, Breast Unit, Azienda Ospedaliero-Universitaria Careggi, 50134 Florence, Italy"},{"name":"Department of Experimental and Clinical Biomedical Sciences \u201cM. Serio\u201d, University of Florence, 50134 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9332-4677","authenticated-orcid":false,"given":"Enrico","family":"Franceschi","sequence":"additional","affiliation":[{"name":"Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"given":"Paola","family":"Gaviani","sequence":"additional","affiliation":[{"name":"Neuroncology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5485-1260","authenticated-orcid":false,"given":"Michela","family":"Buglione di Monale e Bastia","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Universit\u00e0 di Brescia and Spedali Civili Hospital, 25123 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7451-8476","authenticated-orcid":false,"given":"Gian Luca","family":"De Salvo","sequence":"additional","affiliation":[{"name":"Clinical Research Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4201-5852","authenticated-orcid":false,"given":"Alba","family":"Fiorentino","sequence":"additional","affiliation":[{"name":"UOC Radioterapia Oncologica, Ente Ecclesiastico Ospedale F Miulli, 70021 Acquaviva delle Fonti (BA), Italy"},{"name":"Dipartimento di Medicina e Chirurgia, Universit\u00e0 LUM, 70010 Casamassima (BA), Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8351-5952","authenticated-orcid":false,"given":"Anna","family":"Tesei","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, 47014 Meldola (FC), Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0434-8533","authenticated-orcid":false,"given":"Tommaso","family":"Mazza","sequence":"additional","affiliation":[{"name":"Laboratory of Bioinformatics, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo (FG), Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1316-2132","authenticated-orcid":false,"given":"Giuseppe","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-7136","authenticated-orcid":false,"given":"Stefano","family":"Indraccolo","sequence":"additional","affiliation":[{"name":"Basic and Translational Oncology Unit, Veneto Institute of Oncology IOV-IRCCS, 35128 Padua, Italy"},{"name":"Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e2300527","DOI":"10.1200\/PO.23.00527","article-title":"Regorafenib in Patients With Solid Tumors With BRAF Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study","volume":"8","author":"Sahai","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ijc.25864","article-title":"Regorafenib (BAY 73-4506): A New Oral Multikinase Inhibitor of Angiogenic, Stromal and Oncogenic Receptor Tyrosine Kinases with Potent Preclinical Antitumor Activity","volume":"129","author":"Wilhelm","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Daudigeos-Dubus, E., Le Dret, L., Lanvers-Kaminsky, C., Bawa, O., Opolon, P., Vievard, A., Villa, I., Pag\u00e8s, M., Bosq, J., and Vassal, G. (2015). Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142612"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/erm.2024.8","article-title":"Regorafenib and Glioblastoma: A Literature Review of Preclinical Studies, Molecular Mechanisms and Clinical Effectiveness","volume":"26","author":"Mongiardi","year":"2024","journal-title":"Expert Rev. Mol. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(18)30675-2","article-title":"Regorafenib Compared with Lomustine in Patients with Relapsed Glioblastoma (REGOMA): A Multicentre, Open-Label, Randomised, Controlled, Phase 2 Trial","volume":"20","author":"Lombardi","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1158\/1078-0432.CCR-19-4055","article-title":"Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker Analysis","volume":"26","author":"Indraccolo","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102943","DOI":"10.1016\/j.esmoop.2024.102943","article-title":"REGOMA-OSS: A Large, Italian, Multicenter, Prospective, Observational Study Evaluating the Efficacy and Safety of Regorafenib in Patients with Recurrent Glioblastoma","volume":"9","author":"Caccese","year":"2024","journal-title":"ESMO Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13046-025-03346-2","article-title":"AMP-Activated Protein Kinase Mediates Adaptation of Glioblastoma Cells to Conditions of the Tumor Microenvironment","volume":"44","author":"Lorenz","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Jones, J.E.C., Esler, W.P., Patel, R., Lanba, A., Vera, N.B., Pfefferkorn, J.A., and Vernochet, C. (2017). Inhibition of Acetyl-CoA Carboxylase 1 (ACC1) and 2 (ACC2) Reduces Proliferation and De Novo Lipogenesis of EGFRvIII Human Glioblastoma Cells. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169566"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yu, W., Li, S., Guo, D., He, J., and Wang, Y. (2022). Acetyl-CoA Carboxylases and Diseases. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.836058"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1128\/MCB.00166-06","article-title":"5\u2032-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments","volume":"26","author":"Laderoute","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/0008-5472.CAN-12-3876","article-title":"AMPK: A Contextual Oncogene or Tumor Suppressor?","volume":"73","author":"Liang","year":"2013","journal-title":"Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41556-018-0126-z","article-title":"AMP Kinase Promotes Glioblastoma Bioenergetics and Tumour Growth","volume":"20","author":"Chhipa","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/00005072-200606000-00001","article-title":"\u2018Pseudopalisading\u2019 Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis","volume":"65","author":"Rong","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.molcel.2010.02.018","article-title":"MicroRNA-451 Regulates LKB1\/AMPK Signaling and Allows Adaptation to Metabolic Stress in Glioma Cells","volume":"37","author":"Godlewski","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_16","first-page":"vdab133","article-title":"Receptor Tyrosine Kinases as Druggable Targets in Glioblastoma: Do Signaling Pathways Matter?","volume":"3","author":"Qin","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/jnci\/djt282","article-title":"Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers","volume":"105","author":"Polley","year":"2013","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1200\/JCO.2015.63.3651","article-title":"Biomarker: Predictive or Prognostic?","volume":"33","author":"Ballman","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1200\/JCO.19.00367","article-title":"Molecular Evolution of IDH Wild-Type Glioblastomas Treated with Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study","volume":"38","author":"Draaisma","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1200\/JCO-25-01137","article-title":"Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II\/III Bayesian Randomized Platform Trial","volume":"44","author":"Wen","year":"2026","journal-title":"J. Clin. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.25259\/Cytojournal_56_2023","article-title":"Contemporary Art of Cell-Block Preparation: Overview","volume":"21","author":"Saharti","year":"2024","journal-title":"Cytojournal"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/jpi.jpi_82_18","article-title":"Introduction to Digital Image Analysis in Whole-Slide Imaging: A White Paper from the Digital Pathology Association","volume":"10","author":"Aeffner","year":"2019","journal-title":"J. Pathol. Inform."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/(SICI)1097-0258(20000229)19:4<441::AID-SIM349>3.0.CO;2-N","article-title":"Sample Size Considerations for the Evaluation of Prognostic Factors in Survival Analysis","volume":"19","author":"Schmoor","year":"2000","journal-title":"Stat. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cmpb.2003.10.004","article-title":"Adjusted Survival Curves with Inverse Probability Weights","volume":"75","author":"Cole","year":"2004","journal-title":"Comput. Methods Programs Biomed."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards Best Practice When Using Inverse Probability of Treatment Weighting (IPTW) Using the Propensity Score to Estimate Causal Treatment Effects in Observational Studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"Mice: Multivariate Imputation by Chained Equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J. Stat. Softw."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7789\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:56:52Z","timestamp":1788256612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":27,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177789"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177789","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]}}}